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Abstract 
 
 
Ailanthus altissima Swingle (Simaroubaceae) is a medicinal plant used in traditional medicine as an 
antiviral and an antitumoral drug. Its roots have been successively extracted, at room temperature, with 
solvents of increasing polarity. The extracts were tested for their antiproliferative activity on HeLa 
(human cervical carcinoma cell line), at a dose of 10 µg/mL. The chloroform extract, the most active in 
biological assays, was fractionated on a silica-gel column: the fractions obtained were assayed on the 
proliferation of the same cellular line, at a dose of 10 mg/mL. The most active fraction (100% of cytotoxic 
activity) demonstrated to contain a single substance. The identification of this active substance, 
recognized as 1-methoxy-canthin-6-one, was performed by NMR methods. This indole alkaloid has shown 
antiproliferative and proapoptotic effects on several tumoral cell lines. In particular, it provoked 
mitochondrial membrane depolarization, mitochondrial release of cytochrome c and Smac/DIABLO, and 
caspase 3 activation on Jurkat cells (human leukemia cell line). The compound was active also on other 
tumor cell lines, HuH7 (hepatocellular carcinoma), NPA (human papillary carcinoma), and ARO 
(anaplastic thyroid cell line): the apoptosis-inducing activity was evident at a concentration of 
< 10 µmol/L until half maximal at about 40 µmol/L. Peripheral blood mononuclear cells (PBMC) from 
healthy subjects have been used as control; in these cells, the alkaloid showed no proapoptotic activity. 
The effects of 1-methoxy-canthin-6-one, in combination with TRAIL (human recombinant tumor necrosis 
factor-related apoptosis-inducing ligand), has also been investigated on Jurkat cells using suboptimal 
concentrations of both agents, showing 45% apoptosis. Also, the TMRE (tetramethylrhodamine ethyl 
ester) bioassay resulted in a definite mitochondrial membrane depolarization, when alkaloid and TRAIL 
are used together, always using their suboptimal concentrations. The study of the possible synergism has 
shown that the alkaloid increases TRAIL R1 receptors, inducing JNK activation and c-Jun 
phosphorylation. JNK inhibition reduces only partly the synergism between alkaloid and TRAIL; 
therefore, other factors take part in TRAIL-induced apoptosis, besides TRAIL R1 upregulation. In order to 
obtain more information about biological properties of 1-methoxy-canthin-6-one and to investigate on 
chemical requirements responsible for its biological activity, a series of novel 1,4-disubstituted and 1,4,9-
trisubstituted β-carbolines and tetracyclic derivatives were designed and synthesized. In vitro cytotoxic 
activities of these compounds were studied in a human tumor cell line panel. Almost all compounds 
demonstrated antiproliferative effects, in particular against prostate cancer cells PC-3, with an IC50 values 
ranging between 60 and 8 µM. The most active derivatives were tested to evaluate the possible interaction 
with DNA and inhibition of topoisomerase I. None of these compounds were observed to stabilize the 
DNA–Topo I complex, thereby poisoning the reaction. In particular, 3-benzyl-1-methoxy-canthin-6-
onium bromide exhibited strong inhibition of Topo I, with IC50 of 17.77 µM. 
 
